Rituximab in the treatment of interstitial lung disease associated with antisynthetase syndrome: a multi-center retrospective case review

OBJECTIVE: To assess clinical outcomes including imaging findings on computed tomography (CT), pulmonary function testing (PFT), and glucocorticoid use in patients with the antisynthetase syndrome (AS) and interstitial lung disease (ILD) treated with rituximab (RTX). METHODS: We retrospectively iden...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Rheumatol
Autors principals: Doyle, Tracy J., Dhillon, Namrata, Madan, Rachna, Cabral, Fernanda, Fletcher, Elaine A., Koontz, Diane C., Aggarwal, Rohit, Osorio, Juan C., Rosas, Ivan O., Oddis, Chester V., Dellaripa, Paul F.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984657/
https://ncbi.nlm.nih.gov/pubmed/29606668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.170541
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars